A. Evangelista

发表

Automated and Manual Systems for Antimicrobial Susceptibility Testing of Bacteria

A. Evangelista, J. Karlowsky, 2016 .

Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States. Tracking Resistance in the United States Today. The Surveillance Network.

A. Evangelista, J. Karlowsky, D. Sahm, 2002, International journal of antimicrobial agents.

Antimicrobial activity among multidrug-resistant Streptococcus pneumoniae isolated in the United States, 2001-2005.

A. Evangelista, D. Sahm, C. Thornsberry, 2008, Postgraduate medicine.

The Seasonal End of Human Coronavirus Hospital Admissions with Implications for SARS-CoV-2

A. Evangelista, 2020, medRxiv.

Stable antimicrobial susceptibility rates for clinical isolates of Pseudomonas aeruginosa from the 2001-2003 tracking resistance in the United States today surveillance studies.

A. Evangelista, J. Karlowsky, D. Sahm, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Prevalence of Single Mutations in Topoisomerase Type II Genes among Levofloxacin-Susceptible Clinical Strains of Streptococcus pneumoniae Isolated in the United States in 1992 to 1996 and 1999 to 2000

K. Bush, A. Evangelista, D. Sahm, 2002, Antimicrobial Agents and Chemotherapy.

Cross-resistance, relatedness and allele analysis of fluoroquinolone-resistant US clinical isolates of Streptococcus pneumoniae (1998-2000).

K. Bush, A. Evangelista, D. Sahm, 2003, The Journal of antimicrobial chemotherapy.

Predominance of 23S rRNA Mutants among Non-Erm, Non-Mef Macrolide-Resistant Clinical Isolates of Streptococcus pneumoniae Collected in the United States in 1999-2000

K. Bush, A. Evangelista, D. Sahm, 2005, Antimicrobial Agents and Chemotherapy.

Clinical Manifestations and Molecular Characterization of Pertactin-Deficient and Pertactin-Producing Bordetella pertussis in Children, Philadelphia 2007–2014

A. Evangelista, S. Long, A. Queenan, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Antimicrobial Susceptibility and Molecular Detection of Pertactin-producing and Pertactin-Deficient Bordetella pertussis

A. Evangelista, S. Long, Jennifer Vodzak, 2017, The Pediatric infectious disease journal.

Pertactin-negative variants of Bordetella pertussis in the United States.

A. Evangelista, A. Queenan, P. Cassiday, 2013, The New England journal of medicine.

Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: results from the TRUST Surveillance Program, 1999-2000.

A. Evangelista, J. Karlowsky, D. Sahm, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Infrequent occurrence of single mutations in topoisomerase IV and DNA gyrase genes among US levofloxacin-susceptible clinical isolates of Streptococcus pneumoniae from nine institutions (1999-2003).

K. Bush, A. Evangelista, D. Sahm, 2006, The Journal of antimicrobial chemotherapy.

Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States: results from the TRUST Surveillance Program (1998-2002).

A. Evangelista, J. Karlowsky, D. Sahm, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Susceptibilities to Levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Clinical Isolates from Children: Results from 2000-2001 and 2001-2002 TRUST Studies in the United States

G. Noel, A. Evangelista, J. Karlowsky, 2003, Antimicrobial Agents and Chemotherapy.

In vitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila, Mycoplasma pneumoniae and Chlamydia pneumoniae from North America and Europe.

A. Evangelista, J. Karlowsky, M. Jones, 2002, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Effects of the 7-valent pneumococcal conjugate vaccine on U.S. levofloxacin-resistant Streptococcus pneumoniae.

K. Bush, A. Evangelista, D. Sahm, 2008, Microbial drug resistance.

Sterility Duration of Preprimed Extracorporeal Membrane Oxygenation Circuits.

A. Evangelista, Arun Chopra, V. Tan, 2018, The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG.

Invitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila, Mycoplasma pneumoniae and Chlamydia pneumoniae from North America and Europe

A. Evangelista, J. Karlowsky, M. Jones, 2014 .

Pharmacokinetics of the Meropenem Component of Meropenem‐Vaborbactam in the Treatment of KPC‐Producing Klebsiella pneumoniae Bloodstream Infection in a Pediatric Patient

A. Evangelista, Arun Chopra, J. Cies, 2018, Pharmacotherapy.

Comparison of five different susceptibility test methods for detecting antimicrobial agent resistance among Haemophilus influenzae isolates.

R. Clárk, A. Evangelista, J. Mortensen, 1996, Diagnostic microbiology and infectious disease.

Rapid Systems and Instruments for the Identification of Bacteria

P. Bourbeau, A. Truant, A. Evangelista, 2002 .

Tracking resistance among bacterial respiratory tract pathogens: summary of findings of the TRUST Surveillance Initiative, 2001-2005.

A. Evangelista, D. Sahm, C. Thornsberry, 2008, Postgraduate medicine.

A diagnostic key employing biological reactions for differentiating pathogenic Corynebacterium genitalium (NSU corynebacteria) from commensals of the urogenital tract.

A. Evangelista, G. Furness, 1978, Investigative urology.

Analysis of the Cell Wall Constituents of Corynebacterium genitalium

A. Evangelista, M. Lechevalier, A. Saha, 1978 .

Bacteriuria screening: evaluation of current methods.

A. Evangelista, 1987, Advances in experimental medicine and biology.

Stratified analysis of multidrug-resistant Escherichia coli in US health care institutions.

A. Evangelista, D. Sahm, N. Brown, 2008, Postgraduate medicine.

Antimicrobial resistance trends among sinus isolates of Streptococcus pneumoniae in the United States (2001–2005)

A. Evangelista, M. Benninger, D. Sahm, 2007, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Rapid isolation and presumptive diagnosis of uropathogens by using membrane filtration and differential media

T. R. Freeman, A. Evangelista, T. E. Day, 1991, Journal of Clinical Microbiology.

RapidIsolation andPresumptive Diagnosis ofUropathogens by UsingMembraneFiltration andDifferential Media

A. Evangelista, T. E. Day, 1991 .

Corynebacterium pseudogenitalium sp. nov. Commensals of the human male and female urogenital tracts.

A. Evangelista, S. Sambury, G. Furness, 1979, Investigative urology.

Rapid Systems and Instruments for Antimicrobial Susceptibility Testing of Bacteria

Alan T. Evangelista, Allan L. Truant, A. Truant, 2002 .

Pertactin-negative variants of Bordetella pertussis in the United States.

A. Evangelista, A. Queenan, P. Cassiday, 2013, The New England journal of medicine.